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ABSTRACT 
 
Introduction 
Grading of chronic aortic (AR) and mitral regurgitation (MR) severity 
can be obtained by echocardiography and cardiovascular magnetic 
resonance (CMR). The aims of the four studies were: (1) to establish 
echocardiographic thresholds for left ventricular (LV) dimensions 
indicating severe chronic AR or MR, using CMR as reference, (2) to 
elucidate the main cause of echocardiographic underestimation of LV 
dimensions compared with CMR, (3) to systematically compare three 
indirect CMR MR quantification methods (‘standard’, ‘volumetric’ and 
‘flow’ method), as well as (4) to establish CMR- and quantification 
method-specific thresholds indicating hemodynamically significant 
chronic AR or MR benefiting from surgery. 
 
Methods 
The first prospective study comprised a total of 93 (AR (n=44), MR 
(n=49)), the second 45 (healthy volunteers (n=20), AR (n=17), MR 
(n=8)), the third 52 (healthy volunteers (n=16), MR (n=36)) and the 
fourth 78 participants (AR (n=38), MR (n=40)). Two-dimensional 
(2DE) and real-time three-dimensional echocardiography (RT3DE) as 
well as CMR was performed in all participants. Operated patients with 
severe AR/MR, according to 2DE, underwent also post-surgical 
scans. Furthermore, a multimodality phantom model was investigated. 
 
Results 
(1) Linear dimensions could not sufficiently identify severe LV 
dilatation, in contrast to 2DE volumes, which showed an excellent 
(AR) or good (MR) diagnostic ability. The diagnostic ability was less 
powerful for RT3DE volumes. (2) All modalities delineated the 
phantom model with high precision. In vivo, 2DE/RT3DE under-
 estimated LV short-axis end-diastolic linear, areal and all volumetric 
dimensions significantly compared with CMR, but not short-axis end-
systolic linear and areal dimensions. (3) The ‘standard’ method 
determined significantly larger regurgitant volumes (RV) and fractions 
(RF), in contrast to the ‘volumetric’ and ‘flow’ method, which 
determined similar results. This affected the grading of severity in 
operated MR patients. (4) In operated patients, application of current 
RF thresholds by CMR led to frequent downgrading compared with 
2DE. Furthermore, CMR- and quantification method-specific 
thresholds were established, which were lower than recognized 
guideline criteria. 
 
Conclusions 
(1) LV volumes obtained by 2DE/RT3DE can support the diagnosis of 
severe AR and MR, when other causes of LV dilation have been 
considered. (2) Echocardiographic underestimation of LV dimensions 
is mainly due to inherent technical differences in the ability to 
differentiate trabeculated from compact myocardium. (3) The choice of 
indirect CMR MR quantification method can affect the grading of 
regurgitation severity and thereby eventually the clinical decision-
making. (4) CMR grading of chronic AR and MR severity should be 
based on modality- and quantification method-specific thresholds to 
assure appropriate clinical decision-making. 
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 SAMMANFATTNING PÅ SVENSKA 
 
Introduktion 
Indelning av kronisk aorta- (AI) och mitralisinsufficiens (MI) i olika 
svårighetsgrader kan genomföras med hjälp av ekokardiografi och 
kardiovaskulär magnetresonans (KMR). Syftet med de fyra studierna 
var: (1) att etablera ekokardiografiska tröskelvärden för 
vänsterkammardimensioner som indikerar stor AI eller MI med KMR 
som referens, (2) att belysa huvudorsaken för den ekokardiografiska 
underskattningen av vänsterkammardimensioner jämfört med KMR, 
(3) att jämföra tre indirekta KMR metoder för kvantifiering av MI 
(‘standard’, ‘volymetrisk’ och ‘flödes’ metod), och (4) att etablera KMR- 
och kvantifieringsmetodspecifika tröskelvärden som indikerar 
hemodynamisk betydande AI eller MI som har nytta av kirurgi.  
 
Metoder 
Första prospektiva studien omfattar 93 (AI (n=44), MI (n=49)), andra 
studien 45 (friska frivilliga (n=20), AI (n=17), MI (n=8)), tredje studien 
52 (friska frivilliga (n=16), MI (n=36)) och fjärde studien 78 deltagare 
(AI (n=38), MI (n=40)). Tvådimensionell (2DE) och tredimensionell 
ekokardiografi (3DE) samt KMR genomfördes på alla deltagare. 
Opererade patienter med stor AI/MI, enligt 2DE, genomgick också 
undersökningar efter kirurgi. Dessutom undersöktes en multimodal 
fantom modell. 
 
Resultat 
(1) Lineära dimensioner kunde inte identifiera betydande 
vänsterkammardilatation i tillräkligt utsträckning, däremot visade 2DE 
 volymer excellent (AI) eller bra (MI) diagnostisk förmåga. Den 
diagnostiska förmågan var sämre för 3DE. (2) Alla modaliteter kunde 
avbilda fantomdimensionerna med hög precision. In vivo 
underskattade 2DE/3DE vänsterkammarens slutdiastoliska diameter 
och area i kortaxel och alla volymer, men inte den slutsystoliska 
diameter och area i kortaxel. (3) ‘Standard’ metoden kvantifierade 
signifikant större regurgitationsvolymer (RV) och fraktioner (RF) 
jämförd med ‘volymetrisk’ och ‘flödes’ metod, som kom fram till 
liknande resultat. Skillnaden mellan metoderna påverkade 
graderingen av svårighetsgraden i opererade patienter.                    
(4) Tillämpning av RF tröskelvärden enligt de aktuella behandlings-
riktlinjerna gällande KMR ledde i opererade patienter ofta till 
nedgradering jämfört med 2DE. Dessutom etablerades KMR- och 
kvantifieringsmetodspecifika tröskelvärden, som var lägre än de 
aktuella tröskelvärdena från behandlingsriktlinjerna. 
 
Slutsatser 
(1) 2DE/3DE vänsterkammarvolymer kan stödja diagnosen av stor AI 
och MI, när andra orsaker för kammardilatation har övervägts.          
(2) Ekokardiografisk underskattning av vänsterkammardimensionerna 
orsakas huvudsakligen av tekniska skillnader i förmågan att skilja 
trabekulerad från kompakt myokard. (3) Val av indirekt KMR 
kvantifieringsmetod gällande MI kan påverka gradering och därmed 
eventuellt kliniskt beslutsfattande. (4) KMR gradering av kronisk AI 
och MI bör baseras på modalitets- och kvantifieringsmetodspecifika 
tröskelvärden för att säkerställa ett korrekt kliniskt beslutsfattande.
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1 INTRODUCTION 
 
Valvular heart disease (VHD), although not as common as coronary 
artery disease or heart failure, is an important clinical entity, which is 
expected to increase in prevalence with the aging population (1-3). 
Over the past decades, important changes have occurred in Western 
countries concerning the distribution of patient characteristics and 
etiologies. These changes are characterized by a continuous increase 
in the incidence of degenerative valve disease due to an aging 
population and a simultaneous successive decline in rheumatic valve 
disease due to improved living conditions and health care (4). The 
increase in the proportion of elderly patients poses also additional 
challenges for the clinical management and leads to a higher 
intervention risk, as multiple co-morbidities are a frequent finding in 
this patient population (1,2). While few changes have occurred 
concerning the medical therapy of VHD, new surgical interventions 
and more recently transcatheter interventions have led to a shift in the 
overall treatment paradigms (5,6). Furthermore, early surgery in 
asymptomatic patients has been advocated (5-10). To assure 
appropriate clinical decision-making and timing of intervention, 
accurate assessment of disease severity is imperative, which is 
nowadays mainly based on non-invasive imaging techniques such as 
echocardiography and/or cardiovascular magnetic resonance (CMR). 
Despite all, the diagnosis and management of VHD is still mainly 
based on expert consensus summarized in the current guidelines 
(5,6), as the overall level of evidence is scarce mainly due to the lack 
of a true diagnostic “gold standard” and large randomized clinical 
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trials. Finally, there is evidence for a wide clinical practice gap in 
patients with proven VHD as a result of the inadequate translation of 
the existing guidelines into clinical practice (11,12). This leaves, 
altogether, much room for improvement in the field of VHD. 
 
1.1 Chronic aortic regurgitation 
Chronic aortic regurgitation (AR), characterized by the diastolic 
backward flow of blood from the aorta into the left ventricle (Figure 1), 
results from malcoaptation of the aortic valve due to abnormalities of 
the aortic leaflets, their supporting structures (aortic annulus and root), 
or both (13-15). 
 
 
Figure 1 – Visualization of aortic regurgitation using color Doppler echocardiography 
and cardiovascular magnetic resonance (CMR; balanced steady-state free precession 
sequence). 2DE, two-dimensional echocardiography 
 
The most common cause of chronic AR in western countries is 
congenital (bicuspid aortic valve with associated aortic disease) or 
degenerative disease (such as annuloaortic ectasia) (13,14). The 
prevalence of AR in western countries ranges from 0.1% in subjects 
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45-54 years-old to 2% in those ≥ 75 years of age (1). AR is usually 
discovered by clinical examination, manifested as a characteristic 
decrescendo diastolic murmur, or incidentally by echocardiography or 
another non-invasive imaging modality. 
        Chronic AR is characterized by a combined volume and pressure 
overload to which the left ventricle responds with a combined 
eccentric and concentric hypertrophy (16-18). Volume overload is 
caused by the regurgitant volume (RV), which corresponds with the 
severity of AR, and pressure overload results from secondary systolic 
hypertension, which occurs due to an increased total aortic stroke 
volume, as the normal stroke volume plus RV is ejected into the aorta 
during systole (16). Furthermore, systolic hypertension is considered 
to contribute to a cycle of progressive dilatation of the aortic root, 
which leads to a subsequent worsening of AR (13). The degree of AR 
is defined by the severity of the valvular lesion (corresponding to the 
effective regurgitant orifice), the resulting volume overload (quantified 
as the RV or regurgitant fraction (RF)), the driving force (pressure 
gradient between the aorta and left ventricle) and the compliance of 
the left ventricle and ascending aorta. Progression of AR, from mild 
over moderate to severe regurgitation, is an individual process 
occurring at a variable pace and involves a complicated interaction of 
several factors, including AR severity, leaflet and aortic root 
pathology, as well as the adaptive response of the left ventricle. Mild 
and moderate AR is both generally benign and even severe AR 
usually remains asymptomatic for many years. Nonetheless, 
symptoms are an unreliable marker of AR severity and correlate 
poorly with left ventricular (LV) dysfunction (19). Morbidity and 
mortality of the disease is related to the severity of regurgitation, 
etiology, presence of symptoms, as well as size and function of the 
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left ventricle (20-25). The overall goal of treatment is the avoidance of 
death, relief of symptoms, prevention of the development of heart 
failure and avoidance of aortic complications, which can currently only 
be achieved by surgical intervention (26). Therefore, surgery is 
indicated in patients with chronic severe AR who develop symptoms, 
LV systolic dysfunction, severe LV dilatation and/or severe dilatation 
of the aortic root or ascending aorta (5,6). 
 
1.2 Chronic mitral regurgitation 
Chronic mitral regurgitation (MR), characterized by the systolic 
backward flow of blood from the left ventricle into the left atrium 
(Figure 2), results either from disorders of the valve leaflets 
(primary/organic MR) or the mitral apparatus due to an altered LV 
geometry (secondary/functional MR) (13-15). In the following, we will 
focus on primary MR, which is in the western world most frequently 
caused by degenerative valve disease, with an estimated incidence of 
a 
 
Figure 2 – Visualization of mitral regurgitation using color Doppler echocardiography 
and cardiovascular magnetic resonance (CMR; balanced steady-state free precession 
sequence). 2DE, two-dimensional echocardiography 
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2 to 3 % (2,27). The most common finding in degenerative mitral valve 
disease is leaflet prolapse, caused by elongation or rupture of the 
chordae tendineae, resulting in leaflet malcoaptation during ventricular 
contraction and subsequent MR. Mitral valve prolapse, defined as 
systolic atrial displacement of the mitral valve by a minimum of 2 mm 
above the mitral annulus, can be an inheritable condition, linked to 
markers on chromosome 16p11.2-p12.1, 11p15.4 and 13q31.3-q32.1 
(28-30). It comprises a wide clinical spectrum, ranging from single 
chordal rupture with secondary prolapse of an isolated segment in an 
otherwise healthy valve (fibroelastic deficiency, older patients), to 
prolapse of multiple segments involving one or both leaflets in a valve 
with excess tissue and an enlarged mitral annulus (myxomatous 
degeneration/Barlow’s disease, younger patients) (31-35). MR is 
usually discovered by clinical examination, manifested as a 
characteristic holosystolic murmur, or incidentally by echo-
cardiography or another non-invasive imaging modality. 
        Chronic MR causes sole volume overload to which the left 
ventricle responds with eccentric hypertrophy and the left atrium with 
dilatation (14). The degree of MR is defined by the severity of the 
valvular lesion (corresponding to the effective regurgitant orifice), the 
resulting volume overload (quantified as the RV and RF), the driving 
force (pressure gradient between the left ventricle and atrium) and the 
compliance of the left atrium. Progression of MR is an individual 
process occurring at a variable pace and is usually caused by rupture 
of the elongated chordae, resulting in unsupported leaflet segments 
and subsequently more severe MR. This occurs in up to 12% of 
patients over an average follow-up period of 1.5 years, and is more 
common in men and older patients (36-38). Mild and moderate MR is 
both considered benign, in contrast to severe MR. Morbidity and 
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mortality of the disease is related to the severity of regurgitation, 
presence of symptoms, size of the left atrium, size and function of the 
left ventricle, as well as development of atrial fibrillation and 
pulmonary hypertension (39-44). Similar to AR, surgical intervention is 
currently the most effective way of treating severe primary MR and 
mitral valve repair is the preferred method, if applicable (45). Surgery 
is indicated in patients with severe primary MR who develop 
symptoms, LV systolic dysfunction, severe LV dilatation, new-onset 
atrial fibrillation and/or severe pulmonary hypertension (5,6). Recently, 
the concept of earlier surgical intervention has been proposed, 
although controversy exists whether asymptomatic patients with 
severe MR and normal LV function should undergo elective mitral 
valve repair or not (8,34,46). 
 
1.3 Grading of regurgitation severity  
Accurate grading of regurgitation severity is of utmost clinical 
importance, but one of the most difficult problems in VHD mainly due 
to the lack of a true “gold standard” and the dependence on changing 
hemodynamic conditions. Grading of regurgitation severity is 
important since mild regurgitation does not lead to remodeling of the 
cardiac chambers, whereas severe regurgitation is associated with 
substantial remodeling, morbidity and mortality (Figure 3) (20-25,39-
44). Historically, angiography has been widely used for the grading of 
regurgitation severity, even as a reference method for 
echocardiography and CMR (47-53). However, angiographic grading 
itself has several limitations and is, nowadays, considered inferior to 
echocardiography and CMR. Echocardiography is currently the first-
line diagnostic tool for the grading of regurgitation severity and CMR 
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the second-line diagnostic tool in cases of echocardiographic 
uncertainty (5,6). Regurgitation severity grades, which have 
historically ranged between three and five grades, are presently, 
according to a widely accepted consensus, classified into three 
grades, namely mild, moderate and severe (Figure 3) (5,6,54-56). 
 
 
Figure 3 – Grading of regurgitation severity as mild, moderate and severe, including 
the development of cardiac remodeling and symptoms in relation the regurgitation 
severity. 
 
Consequently, to assure appropriate clinical decision-making and 
timing of intervention, non-invasive imaging techniques are needed 
that can accomplish the grading of regurgitation severity with high 
precision and reproducibility. Nonetheless, interpretation of the 
imaging results should always be performed in the clinical context at 
the time of examination. 
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1.4 Echocardiography 
Echocardiography is currently, as previously mentioned, the first-line 
diagnostic tool in the evaluation of VHD and uses an “integrative 
approach” of several qualitative, semi-quantitative and quantitative 
parameters for the grading of regurgitation severity (5,6,54-56). 
However, due to feasibility and reproducibility issues, especially when 
using parameters based on color Doppler echocardiography, grading 
of regurgitation severity is often challenging and sometimes only 
based on relatively few parameters (57,58). Furthermore, current 
guidelines provide no information concerning the weighting of the 
different parameters and how to approach cases of diagnostic 
incongruence. 
        The assessment of LV linear and volumetric dimensions is an 
integral part in the evaluation of patients with both chronic AR and MR 
(5,6,54-56). Although LV dilatation is a hallmark of severe chronic 
regurgitation and LV volumes are an additional valuable quantitative 
parameter in the “integrative approach”, so far current guidelines 
include only thresholds for LV linear dimensions indicating severe LV 
dilatation secondary to severe regurgitation with poor prognosis. In 
contrast, no thresholds are reported for LV linear and volumetric 
dimensions indicating severe regurgitation. The most commonly used 
method for the assessment of LV dimensions is two-dimensional 
echocardiography (2DE), which nonetheless underestimates LV 
volumes significantly and has a lower reproducibility compared with 
CMR (59,60). Real-time three-dimensional echocardiography 
(RT3DE) overcomes some of the limitations of 2DE and is therefore 
considered to provide higher levels of agreement and reproducibility 
compared with CMR (61-63). Nonetheless, RT3DE still 
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underestimates LV volumes significantly (64). CMR provides currently 
the most exact assessment of LV volumes with high reproducibility 
and has been validated extensively as a reference method (“gold 
standard”) (65,66). So far, the thresholds of the established 
echocardiographic quantitative parameters have been determined in 
comparison with angiography or other echocardiographic parameters 
(57,67,68). To establish 2DE and RT3DE thresholds for LV linear and 
volumetric dimensions indicating severe chronic AR or MR, we 
decided to use a novel approach by prospectively characterizing 
patients with moderate AR or MR (as determined by 2DE) as well as 
patients with severe AR or MR (as determined by 2DE), undergoing 
surgery according to current guideline criteria, by 2DE and RT3DE, 
using CMR as the reference method (Paper I). Severe LV dilatation 
was defined as an end-diastolic volume (EDV) index above the 50th 
percentile obtained by CMR in patients with hemodynamically 
significant AR or MR and proven surgical benefit. To assure that LV 
dilation was solely due to valvular regurgitation, patients with 
confounding causes of LV enlargement were excluded from the study.  
        As previously mentioned, 2DE and to a lesser degree RT3DE 
underestimate LV volumes significantly in comparison with CMR. 
Several plausible causes contributing to this inter-modality 
discrepancy have been postulated. They include LV foreshortening, 
off-axis views (69,70), inferior image quality (71), use of geometrical 
assumptions for the volumetric calculations (70), differences in the 
endocardial border position and lower spatial resolution by 
echocardiography (72), as well as insufficient compensation for basal 
through-plane motion by CMR (73). In contrast, little is known about 
the ability of the different modalities to delineate simpler LV 
dimensions like diameter and area. We hypothesized that 
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underestimation of the LV dimensions by 2DE and RT3DE in 
comparison with CMR already occurs at the level of the one-
dimensional parameters like diameter and increases successively via 
two-dimensional parameters like area to three-dimensional 
parameters like volume. Through the systematic study of parameters 
with increasing complexity (diameter – area – volume), in a 
multimodality phantom model as well as in vivo, we hoped to gain a 
clearer picture of the main cause of echocardiographic 
underestimation, assuming that the simplest one-dimensional 
parameters are influenced by a lesser degree of interfering factors 
(Paper II). 
 
1.5 Cardiovascular magnetic resonance 
CMR is currently, as previously mentioned, used as a second-line 
diagnostic tool and can also provide a comprehensive assessment of 
chronic AR and MR severity (5,74-76). The assessment of 
regurgitation severity by CMR is mainly based on the quantification of 
the respective aortic or mitral RV and RF. These parameters can be 
obtained by different methods using either solely phase-contrast 
velocity (PC) imaging or a combination of PC imaging and the slice 
summation technique, which determines LV volumes (53,77-79). The 
different CMR quantification methods can, according to our 
experience, differ substantially in their results, suggesting the 
necessity of quantification method-specific CMR thresholds. 
        Quantification of MR can be achieved by a direct and three 
indirect methods. Direct quantification of MR by CMR, using PC 
imaging, can be challenging due to frequently eccentric, sometimes 
direction changing and/or multiple high velocity regurgitant jets, which 
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cause not only difficulties with adequate image plane alignment, but 
also introduce errors in PC imaging (80). Nonetheless, direct MR 
quantification has demonstrated good correlation and agreement with 
indirect CMR methods (80). The most commonly used indirect 
(‘standard’) CMR method, which has been shown to correlate well 
with quantitative Doppler echocardiography (78) and invasive 
measurements (53), quantifies MR by subtracting the aortic forward 
flow (AoFF), obtained by PC imaging, from the LV stroke volume (SV), 
obtained by the slice summation technique. The second indirect 
‘volumetric’ CMR method, which can only be applied in the absence of 
multivalvular disease and intra-cardiac shunt, quantifies MR by 
subtracting the right ventricular SV (RVSV) from the LVSV, both 
obtained by the slice summation technique. This method has shown 
poorer inter- and intra-observer variability in comparison with the 
‘standard’ method (81). The third indirect ‘flow’ CMR method, which 
has been shown to correlate well with color Doppler echocardiography 
and has demonstrated excellent inter-observer variability (79), 
quantifies MR by subtracting the AoFF from the mitral inflow (MiIF), 
both obtained by PC imaging. Although each indirect quantification 
method has been validated against other techniques in a limited 
number of small studies, a systematic comparison of all three indirect 
CMR methods is currently missing in the scientific literature. 
Accordingly, we systematically compared all three indirect 
quantification methods in healthy volunteers without MR, functioning 
as an internal control group, and patients with MR (Paper III). 
        Currently, quantitative grading of regurgitation severity by 2DE 
and CMR is usually based on the same guideline thresholds (5,54). 
Previously, different strategies have been used to identify CMR-
specific thresholds. One approach has been to search for the best 
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concordance between echocardiographic and CMR grading of 
regurgitation severity, which resulted, nonetheless, in contradictory 
results (82,83). Another approach has been to look for the link 
between clinical outcome and CMR regurgitation severity (84). Taken 
together, current evidence, although scarce, indicates that CMR 
thresholds differ most likely substantially from the recognized 
guideline thresholds. We used a novel approach to determine CMR- 
and quantification method-specific thresholds indicating 
hemodynamically significant chronic AR or MR benefiting from 
surgery. To establish these modality- and quantification method-
specific thresholds, we decided to prospectively characterize patients 
with severe AR or MR (as determined by 2DE) undergoing surgery (in 
keeping with current guidelines) as well as patients with moderate AR 
or MR (as determined by 2DE) using CMR (Paper IV). As CMR 
grading of regurgitation severity uses no “integrative approach” of 
several parameters, apart from the determined RV and RF, we even 
set out to determine additional CMR parameters that can support or 
exclude the diagnosis of hemodynamically significant AR or MR 
(Paper IV). Thereby taking the first step towards a multi-parametric 
grading approach by CMR. 
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2 AIMS 
 
The overall aim of this thesis was to shed new light on some of the 
remaining diagnostic challenges in chronic AR and MR when using 
2DE, RT3DE and/or CMR. 
 
Paper I 
To establish 2DE and RT3DE thresholds for LV linear and volumetric 
dimensions indicating severe chronic AR or MR, using CMR as 
reference method. 
 
Paper II 
To investigate the ability of 2DE, RT3DE and CMR to delineate 
dimensions with increasing complexity (diameter – area – volume) in a 
linear and volumetric multimodality phantom model, as well as in the 
left ventricle of healthy volunteers and valvular heart disease patients 
according to the same principles, and by this to further characterize 
the main cause of echocardiographic underestimation of LV 
dimensions. 
 
Paper III 
To compare three indirect CMR methods for MR quantification 
(‘standard’, ‘volumetric’ and ‘flow’ method) to determine their 
agreement in healthy volunteers without MR and patients with MR, to 
study their respective inter- and intra-observer variability, and to 
determine the effect on grading MR severity in relation to the chosen 
method in a subgroup of operated patients with severe MR. 
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Paper IV 
To identify CMR- and quantification method-specific thresholds for 
both the RV index and RF indicating hemodynamically significant 
chronic AR or MR benefiting from surgery, and to determine 
alternative CMR parameters that can support or exclude the diagnosis 
of hemodynamically significant AR or MR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 15	  
3 METHODS 
 
This chapter is a summary of all methods used in the four papers on 
which this thesis is based. For more information, please read the 
methods section of each paper.  
 
3.1 Study population and design 	  
Paper I 
This prospective study comprised 44 AR (moderate (n=20), severe 
(n=24); as determined by 2DE) and 49 MR patients (moderate (n=17), 
severe (n=32); as determined by 2DE). Subsequent surgical treatment 
was performed in 23 AR and 25 MR patients with severe regurgitation 
due to symptoms and/or severe LV remodeling. 
 
Paper II 
The study comprised a phantom and an in vivo analysis of 20 healthy 
volunteers and 25 patients with single moderate or severe AR (n=17) 
and MR (n=8; as determined by 2DE).   
 
Paper III 
This study comprised 16 healthy volunteers and 36 MR patients 
(moderate (n=5), moderate to severe (n=2), severe (n=29); as 
determined by 2DE). Subsequent surgical treatment was performed in 
all patients with severe MR due to symptoms and/or severe LV 
remodeling. 
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Paper IV 
This prospective study comprised 38 AR (moderate (n=15), severe 
(n=23)) and 40 MR patients (moderate (n=15), severe (n=25)). 
Subsequent surgical treatment was performed in all patients with 
severe AR and MR due to symptoms and/or severe LV remodeling. 
 
Exclusion criteria, for all VHD patients in the four studies, were the 
presence of ≥ moderate regurgitation in any other valve, intra-cardiac 
shunt, any other form of relevant cardiac disease, irregular heart 
rhythm or contraindications for CMR imaging. All participants 
underwent a 2DE, RT3DE and CMR exam within four hours. Special 
care was taken to assure high image quality and accurate alignment 
of the image planes. In all operated patients, a second 2DE and CMR 
exam was performed 10 ± 1 months post surgery in all but eight AR 
and eight MR patients, who underwent only a post-surgical 2DE exam 
due to newly obtained relative contraindications for CMR imaging 
(permanent pacemaker, mechanical valve) or unwillingness to perform 
a second CMR scan. Part of every non-invasive imaging exam was 
also the taking of a medical history and the performance of a physical 
examination. Post-surgical scans and follow-ups were performed in 
order to confirm that the initial pre-surgical valvular regurgitation was 
of hemodynamic significance according to the following criteria: 
reduction in EDV index of ≥ 15% and/or relief of symptoms. 
 
3.2 Echocardiography 
2DE and RT3DE were performed using an iE33 or Vivid E9 imaging 
system equipped with a 2D sector array transducer or 3D matrix array 
transducer. Image analysis was performed using EchoPAC or QLAB. 
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Image acquisition, analysis and grading of regurgitation severity were 
performed according to current guidelines (54-56,85,86). 
Echocardiographic exams were approved for final analysis when a 
clear endocardial border was visible in the parasternal long-axis (PLA) 
and short-axis (SA) view to delineate LV linear dimensions or ≥ 75% 
of the endocardial border was seen in the respective projections to 
obtain LV volumetric dimensions (Paper I and II). 
        Standard projections were obtained by 2DE from the parasternal 
and apical window (85). LV linear dimensions were obtained in the 
PLA, SA and apical four-chamber (4CH) view, as the visually largest 
end-diastolic (EDD) and end-systolic diameter (ESD) at the mitral 
chordae level (Paper I and II). LV ejection fraction (EF) from linear 
data was calculated according to the Teichholz formula (Paper I) (87). 
LV length was acquired in the 4CH view from the level of the insertion 
of the mitral valve leaflets to the apex (not included in the published 
article, Paper II). The end-diastolic (EDA) and end-systolic area (ESA) 
was obtained in the SA and 4CH view (Paper II). In Paper II, LV linear 
and areal dimensions were obtained by including both the papillary 
muscles and trabeculae in the LV cavity to assure identical 
endocardial border definition criteria across the modalities. In contrast, 
in Paper I, LV linear dimensions were obtained according to 2DE 
guidelines (85). LV volumetric dimensions were acquired according to 
the biplane method of disks to determine the EDV and end-systolic 
volume (ESV) (85). In general, the analysis was performed according 
to 2DE guidelines, including only the papillary muscles into the LV 
cavity (85), but also according to RT3DE guidelines (Paper II), 
including both papillary muscles and trabeculae in the LV cavity 
(Figure 4) (86). The LVEF was calculated as (EDV-ESV)/EDV x 
100%. 
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Figure 4 – Delineation of left ventricular volumes using two-dimensional (2DE) and 
real-time three-dimensional echocardiography (RT3DE), with respect to the exclusion 
(green dotted lines) or inclusion (red dotted lines) of the trabeculae in the left 
ventricular cavity. 
 
        A full-volume scan was obtained from the apical window by 
RT3DE during a single breath-hold. Subsectors of the image were 
acquired over four to six consecutive heartbeats and then 
subsequently “stitched” together electronically (86). LV linear 
(including length, not included in the published article) and areal 
dimensions were measured as for 2DE from the reconstructed SA and 
long-axis (LA) views derived from the three-dimensional full-volume 
data set (Paper II). Volumetric dimensions were obtained using a 
semi-automated border detection software with a manual correction 
function generating a three-dimensional endocardial shell of the LV 
from which the EDV and ESV were derived on the basis of the voxel 
count inside the generated mesh (88,89). In general, the analysis was 
performed according to RT3DE guidelines, including both papillary 
muscles and trabeculae in the LV cavity (86), but also according to 
2DE guidelines (Paper II), including only the papillary muscles into the 
LV cavity (Figure 4) (85). The LVEF was calculated as for 2DE. 
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3.3 Cardiovascular magnetic resonance 
CMR imaging was performed using a 1.5 Tesla scanner with a Q-body 
coil (phantom model) or five-channel phased-array cardiac coil (in 
vivo). Cine images were acquired using balanced steady-state free 
precession sequences, with artificial electrocardiography (ECG) gating 
and without parallel imaging (phantom model), or with retrospective 
ECG gating and parallel imaging during gentle expiratory breath-hold 
(in vivo). The quantification of the aortic, pulmonary and mitral flow 
was performed using through-plane PC sequences with retrospective 
ECG gating during gentle expiratory breath-hold. PC images were 
acquired perpendicularly aligned to the direction of the blood flow in 
the aortic root at the level of the sinotubular junction (Figure 5B), the 
pulmonary trunk just above the pulmonary valve (Figure 5C) and the 
mitral valve approximately 1 cm below the mitral annulus (ventricular 
side; Figure 5D) (79,90,91). 
 
 
Figure 5 – (A) Delineation of the end-diastolic left ventricular endo- and epicardial 
border (white dots) in the continuous short-axis stack to determine ventricular 
volumes and mass. (B and C) Three-chamber and right-ventricular outflow tract view 
in end-diastole, illustrating the slice position for through-plane phase-contrast velocity 
(PC) imaging (red line), including corresponding PC images, to quantify aortic and 
pulmonary flow (black arrows). (D) Three-chamber view in early diastole, illustrating 
the position for through-plane PC imaging (red line), including corresponding PC 
image, to quantify mitral inflow (black arrow). 
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The potential for background phase errors (BPE) was reduced by 
ensuring that the region of interest (ROI) was for all PC sequences 
aligned in the isocenter of the magnet to minimize magnetic field 
inhomogeneities (90). The initially set velocity encoding range (VENC) 
was subsequently optimized, either in the presence of aliasing or 
when the difference between the initially set VENC and the 
determined maximal velocity was > 25% (92). PC images were in all 
positions performed twice (results are therefore presented as the 
mean of the two measurements). In all studies, the coefficient of 
variation of repeated flow measurements was in the aortic, pulmonary 
and mitral position 5%, 5% and 4% respectively. In all PC 
measurements, effective compensation for BPEs was applied using 
adaptive image filtering (93-95). After compensation, the BPE was in 
all PC images (static tissue) below the current limit of acceptance, 
namely < 0.6 cm/s (96). Image analysis was performed using 
ViewForum. 
        CMR acquired after standardized patient-specific planning a 
series of cine images in the SA view covering the whole heart without 
gap from the atrioventricular ring to the apex, followed by cine images 
in the common long-axis projections (91). LV linear (including length, 
not included in the published article) and areal dimensions were 
obtained as for 2DE (Paper II). LV volumetric dimensions and mass 
were obtained by manual tracing of the endocardial and epicardial 
contour in end-diastole in the successive SA slices of the continuous 
SA stack (Figure 5A). Endocardial contours were subsequently 
propagated through all phases using a semi-automated tracing 
algorithm, followed by manual adjustment, if necessary. Basal 
through-plane motion was compensated for according to a previously 
described method by Alfakih et al. (97). Right ventricular volumes 
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were acquired by manual tracing of the endocardial contour in the 
end-diastolic and end-systolic frames in the successive SA slices of 
the continuous SA stack (Paper III). In the basal slice, only portions 
below the pulmonary valve were included in the volume and sections 
with a thin, non-trabeculated wall were excluded as it was considered 
part of the right atrium (97). Papillary muscles and trabeculae were 
included in both the left and right ventricular cavity. The EDV and ESV 
were automatically computed by the slice summation method. LVSV 
and EF were calculated as SV = EDV-ESV, and EF = SV/EDV x 
100%. The left atrial area (LAA) was determined in end-systole in the 
4CH and two-chamber projection (results are presented as the mean 
of both measurements; Paper IV). Aortic and pulmonary flow was 
determined by delineating the ROI on the respective magnitude 
image, copied onto the phase image and propagated through all 
phases using a semi-automated tracing algorithm, followed by manual 
adjustment, if necessary. Delineation of the mitral valve was 
performed manually for all phases and in case of a closed valve, flow 
was zeroed by the delineation of an extremely small ROI on the 
closed valve (Paper III and IV). By integrating the velocity of each 
pixel in the delineated ROI over one heart cycle, the respective flow 
information was derived (98). 
        Quantification of AR was performed first, by direct flow 
quantification in the aortic root at the level of the sinotubular junction 
(Paper I and IV) (90), and second, by indirect quantification of the RV 
subtracting the pulmonary stroke volume (PuSV) from the LVSV 
(Paper IV). The quantification of MR was performed first according to 
the ‘standard’ method, which calculates the RV by subtracting the 
AoFF from the LVSV (Paper I, III and IV) (53,78). Second, by the 
‘volumetric’ method, which can only be applied in the absence of 
 22	  
multivalvular disease and intra-cardiac shunt, calculating the RV by 
subtracting the RVSV from the LVSV (Paper III) (80,81). Third, by the 
‘flow’ method, which calculates the RV by subtracting the AoFF from 
the MiIF (Paper III and IV) (79). In general, RFs were calculated as 
follows: RV/LVSV x 100% or RV/MiIF x 100%. In Paper III, eight MR 
patients had ≥ mild pulmonary and/or tricuspid regurgitation (as 
determined by 2DE) and were therefore excluded from MR 
quantification using the ‘volumetric’ method. Otherwise, all other 
quantification methods could be applied in all participants. Grading of 
AR and MR severity was performed according to current guideline 
thresholds (5).  
 
3.4 Multimodality phantom model 
The multimodality phantom model, built out of polycarbonate, consists 
of an open cube (160 x 160 x 160 mm) that can be modified to a linear 
model by inserting two centered plates with adjustable predefined 
distances (initial centered spacing 10 mm, followed by a continuous 
increase in distance of 10 mm, max. analyzed distance 100 mm) or to 
a volumetric model by inserting a centered cylinder with a predefined 
central volume (diameter 44 mm, length 66 mm, SA area 16 cm2,     
LA area 29 cm2, volume 100 ml; Figures 6A-C; Paper II). Sufficient 
contrast was achieved by adding potato flour to the water-filled 
phantom model for 2DE/RT3DE and manganese (II) chloride doped 
water for CMR. 
        For 2DE and RT3DE both phantom models were analyzed with 
the transducer centered on the bottom plate, corresponding to an 
apical LA projection (position II), and with the transducer centered on 
a thin side plate, corresponding to a parasternal SA projection 
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(position I, Figures 6B-E). The linear phantom model was examined 
by determining the distance between the plates in LA (at five different 
points of measurement) and SA projections (Figures 6B and 6D). The 
volumetric phantom model was analyzed in LA and SA projections 
concerning diameter (not included in the published article), length (not 
included in the published article) and area (Figure 6C and 6E). 
Volumetric dimensions were acquired for both 2DE and RT3DE 
according to a geometrical cylinder model (π x radius2 x length; not 
included in the published article) and the biplane method of disks, and 
for RT3DE also according to a mesh-based volumetric method. 
 
 
Figure 6 – Image and schematic drawing of the linear and volumetric multimodality 
phantom model (A-C). Echocardiographic assessment was performed with the 
transducer centered on the side plate (I) and with a transducer centered on the 
bottom plate (II). Examples of the analysis of the linear (D/F) and volumetric model 
(E/F) by two-dimensional echocardiography and cardiovascular magnetic resonance 
respectively. Black and white arrows – linear dimensions; Red dotted lines – areal 
dimensions; Bo – bottom plate; PM – point of measurement; Yellow point – focus 
position. Reproduced with permission of the publisher. 
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CMR acquired continuous images without gap in the sagittal and 
transverse planes of the linear and volumetric phantom model. The 
linear and volumetric phantom model was examined according to the 
same principles as 2DE/RT3DE in terms of diameter and area 
(Figures 6B, 6C and 6F). Volumetric dimensions were determined 
using a geometrical cylinder model (not included in the published 
article) and the slice summation method. 
 
3.5 Reproducibility analysis 
Inter-observer variability was assessed in an independent analysis by 
a second observer and intra-observer variability was determined in an 
independent second analysis by the primary observer. Both observers 
were blinded to previous results. 
 
3.6 Statistical analysis 
Agreement between methods was evaluated using the Bland-Altman 
method by calculating the mean difference (MD) ± standard deviation 
(SD) and limits of agreement (LoA; MD ± 1.96 SD) (99). Correlation 
was assessed using the Pearson’s or Spearman’s rank correlation 
coefficient. The significance of the differences between the modalities 
was assessed using a Friedman’s test to determine the overall P-
value (values of < 0.05 were considered significant), followed by a 
post-hoc analysis using a Wilcoxon signed rank test when the initial 
null hypothesis was rejected (P-values of < 0.016 were considered 
significant (Bonferroni correction)). Otherwise, a paired Student's t-test 
or Wilcoxon signed rank test was used for the comparison of 
dependant groups and a Mann-Whitney U test for the comparison of 
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independent groups. Receiver operating characteristics curve (ROC) 
analysis was performed to establish diagnostic thresholds (100). The 
diagnostic performance of the individual thresholds was assessed 
using sensitivity, specificity, positive likelihood ratio (PLR) and 
negative likelihood ratio (NLR) (101,102). The PLR is the ratio 
between the probability of a positive test result in patients with disease 
and the probability of a positive test result in those without disease 
(sensitivity/(1-specificity)). The NLR is the ratio between the 
probability of a negative test result in patients with disease and the 
probability of a negative test result in those without disease ((1-
sensitivity)/specificity). Inter- and intra-observer variability was 
assessed by the coefficient of variation (defined as the (SD of the 
differences between observer measurements/mean of the observer 
measurements) x 100) and repeatability coefficient (defined as 1.96 x 
√(sum of the squares of the differences between observer 
measurements/n)) (99,103). The significance of the squared 
differences in the repeatability coefficient was assessed as above by a 
Friedman’s test followed, if applicable, by a Wilcoxon signed rank test 
or by solely a Wilcoxon signed rank test. Statistical analysis was 
performed using IBM SPSS Statistics 19. 
 
3.7 Ethical considerations 
All studies were conducted according to the Declaration of Helsinki. 
The Regional Ethics Review Board in Gothenburg gave ethical 
approval for the study protocols, and written informed consent was 
obtained from all participants. 
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4 RESULTS 
 
This chapter is a summary of the main results presented in the four 
papers on which this thesis is based. For more information, please 
read the results section of each paper.  
 
4.1 Paper I 
Each included patient had no other underlying cause contributing to 
LV dilation apart form single VHD. All operated patients experienced a 
reduction in EDV index ≥ 15% and/or relief of symptoms. EDD2DE, 
EDV2DE and EDVCMR could be obtained in all participants (n = 93). In 
contrast, EDVRT3DE was only obtained in 71 patients (76%) that fulfilled 
the analysis criteria. 
 
Linear and volumetric dimensions in AR and MR patients 
The EDD2DE, obtained in the PLA, was similar in patients with AR and 
MR (59 ± 6.1 mm versus 58 ± 6.0 mm, P = 0.49). In contrast, the EDV 
between AR and MR patients were significantly different for 2DE   
(197 ± 73 ml versus 148 ± 41 ml, P < 0.0001), RT3DE (220 ± 61 ml 
versus 184 ± 41 ml, P = 0.005) and CMR (310 ± 95 ml versus 263 ± 
60 ml, P = 0.001).  
 
Comparison of LV dimensions obtained by 2DE, RT3DE and CMR 
The overall linear relationship between EDD2DE and EDVCMR was 
moderate (n = 93, r = 0.73, P < 0.0001). Furthermore, the overall 
linear relationship between EDV2DE and EDVCMR as well as EDVRT3DE 
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and EDVCMR was strong (Figure 7). 2DE underestimated EDVs 
significantly in comparison with CMR and the limits of agreement were 
wide. This was to a lesser extent also the case when comparing 
RT3DE with CMR (Figure 7 and 8). There was no difference in the 
obtained LVEF between 2DE and CMR. In contrast, RT3DE 
determined a significantly lower LVEF compared with 2DE and CMR. 
 
 
Figure 7 – Scatterplots and Bland-Altman analyses illustrating the relation between 
end-diastolic volume (EDV) and left ventricular ejection fraction (LVEF) obtained by 
two-dimensional echocardiography (2DE) versus cardiovascular magnetic resonance 
(CMR; upper three plots) and real-time three-dimensional echocardiography (RT3DE) 
versus CMR (lower three plots). Dashed lines indicate the line of identity or the 95% 
limits of agreement (LOA). Horizontal solid lines represent the mean difference (bias). 
R, correlation coefficient 
 
Identification of severe LV dilatation 
Severe LV dilation was defined as an EDVCMR index above the 50th 
percentile in patients undergoing surgery for severe AR or MR. 
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Figure 8 – Comparison of the determined left ventricular (LV) end-diastolic volumes 
and ejection fractions (n=71) obtained by two-dimensional (2DE), real-time three-
dimensional echocardiography (RT3DE) and cardiovascular magnetic resonance 
(CMR). The overall P-value, when comparing all three modalities, was < 0.0001 for 
both parameters. The significance of the differences between the modalities is 
presented as P values. 
 
Table 1 – Diagnostic performance of thresholds indicating marked LV dilatation 
defined as EDVCMR index above the 50th percentile 
 
 
 
 
 
 
AUC 
(95% CI) 
 
 
Threshold 
 
 
Sensitivity 
(95% CI) 
 
 
Specificity 
(95% CI) 
 
 
PLR 
(95% CI) 
 
 
NLR 
(95% CI) 
 
 
Aortic regurgitation 
EDD index   
(cm/m2) 
 
0.86 
(0.74 – 0.97) 
> 3.0 73 
(48 – 89) 
83 
(65 – 92) 
4.3 
(1.8 – 9.9) 
0.32 
(0.14 – 0.8) 
EDV2DE index 
(ml/m2) 
 
0.97 
(0.92 – 1.0) 
> 100 93 
(70 – 99) 
97 
(83 – 99) 
27 
(3.9 – 187) 
0.07 
(0.01 – 0.46) 
EDVRT3DE index 
(ml/m2) 
 
0.99 
(0.96 – 1.0) 
> 115 88 
(53 – 98) 
92 
(74 – 98) 
10.5 
(2.7 – 41) 
0.14 
(0.02 – 0.86) 
Mitral regurgitation 
EDD index   
(cm/m2) 
 
0.71 
(0.56 – 0.85) 
> 3.0 63 
(39 – 82) 
64 
(47 – 78) 
1.7 
(0.9 – 3.1) 
0.59 
(0.30 – 1.2) 
EDV2DE index 
(ml/m2) 
 
0.94 
(0.88 – 1.0) 
> 80 88 
(64 – 97) 
91 
(76 – 97) 
9.6 
(3.2 – 29) 
0.14 
(0.04 – 0.5) 
EDVRT3DE index 
(ml/m2) 
 
0.89 
(0.78 – 0.99) 
> 99 83 
(55 – 95) 
77 
(58 – 89) 
3.6 
(1.7 – 7.6) 
0.22 
(0.06 – 0.8) 
 
 
AUC, area under the curve; CI, confidence interval; CMR, cardiovascular magnetic resonance; EDD, end-
diastolic diameter; EDV, end-diastolic volume; NLR, negative likelihood ratio; PLR, positive likelihood ratio; 
RT3DE, real-time three-dimensional echocardiography; 2DE, two-dimensional echocardiography 
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In patients with AR the 50th percentile for the EDVCMR index was 161 
ml/m2 and the corresponding for MR was 135 ml/m2. The ability of 
2DE and RT3DE to identify severe LV dilatation was tested using 
ROC analyses for AR and MR separately. The area under the curve 
was large for both 2DE and RT3DE EDV indices and moderate to 
large for the EDD indices (Table 1). In both AR and MR, LV linear 
dimensions could not sufficiently identify patients with severe LV 
dilatation. In AR, the diagnostic ability was excellent for both 2DE and 
RT3DE LV volumes with a PLR ≥ 10. In MR, the diagnostic ability was 
overall weaker than in AR and only the 2DE LV volumes displayed a 
good diagnostic ability with a PLR ≥ 5 (Table 1). 
 
4.2 Paper II 
 
Linear and volumetric phantom model 
2DE and RT3DE depicted the linear dimensions of the linear and 
volumetric phantom model in the SA projection with similar precision 
as CMR, and in the LA projection in a depth-dependant manner with 
the smallest absolute error (actual dimension – measured dimension) 
at the level of the focus position (Figure 9). Otherwise, all three 
modalities depicted the areal and volumetric dimensions of the 
volumetric phantom model with high precision (Figure 9). 
 
Left ventricular dimensions in vivo 
The image acquisition protocol was successfully completed in all 
participants. Nonetheless, the obtained data sets did not fulfill the 
strict echocardiographic analysis criteria in all cases and for all 
parameters (Table 2). Patients without sufficiently acquired 2DE and 
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RT3DE data sets (apical window) had significantly larger EDVs 
obtained by CMR than data sets of patients fulfilling the analysis 
criteria (373 ± 118 ml versus 274 ± 51 ml (P = 0.02) and 404 ± 110 ml 
versus 269 ± 46 ml (P = 0.001) respectively). 
 
 
Figure 9 – Dimensions of the linear (A) and volumetric multimodality phantom model 
(B) assessed by two-dimensional echocardiography (2DE), real-time three-
dimensional echocardiography (RT3DE) and cardiovascular magnetic resonance 
(CMR). The linear phantom model dimensions (A) are presented as the mean 
absolute error (AE) ± standard deviation (SD; mean of all acquired distances from 10 
to 100 mm) at each point of measurement (PM). The assessed dimensions of the 
volumetric phantom model (B) are presented as the AE ± SD concerning diameter (at 
each PM), length, area (* short-axis/long-axis) and volume (using different methods). 
Black arrows – linear dimensions; Circle – focus position. Otherwise, abbreviations 
and symbols as in Figure 6 
 
        2DE underestimated the SA-EDD (Table 2) and 4CH-EDD (MD ± 
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SD: -2 ± 4 mm, p = 0.01) significantly compared with CMR, but not the 
SA-ESD (Table 2). RT3DE underestimated the linear dimensions to 
an even higher degree than 2DE (Table 2). In comparison with CMR, 
2DE (MD ± SD: -7 ± 5 mm) and RT3DE (MD ± SD: -8 ± 5 mm) 
underestimated the 4CH-LV length significantly (Table 3).  
 
Table 2 – Comparison of LV dimensions between 2DE, RT3DE and CMR 
 
 
 
 
 
Post-hoc analysis 
 
 
 
 
 
2DE * 
 
 
RT3DE * 
 
 
CMR * 
 
Overall 
P-value 
2DE vs 
RT3DE 
2DE vs 
CMR 
RT3DE  
vs CMR 
 
Diameter (mm) 
 
SA-EDD 63 ± 9  
(35) 
59 ± 7 
(23) 
65 ± 10 
(45) 
< 0.0001 
(19) 
< 0.0001 < 0.0001 < 0.0001 
SA-ESD 44 ± 7  
(34) 
40 ± 5 
(20) 
45 ± 9 
(45) 
0.001 
(16) 
< 0.0001 0.52 0.03 
 
Area (cm2) 
 
SA-EDA 28 ± 9 
(24) 
25 ± 5 
(21) 
33 ± 10 
(45) 
< 0.0001 
(12) 
0.002 < 0.0001 < 0.0001 
SA-ESA 15 ± 5 
(27) 
13 ± 3 
(19) 
16 ± 7 
(45) 
0.01 
(11) 
0.003 0.12 0.04 
 
Volume (ml) 
 
EDV 171 ± 58 
(24) 
171 ± 50 
(25) 
250 ± 107 
(45) 
< 0.0001 
(21) 
0.57 < 0.0001 < 0.0001 
ESV 72 ± 27 
(24) 
72 ± 22 
(25) 
99 ± 52 
(45) 
< 0.0001 
(21) 
0.96 < 0.0001 < 0.0001 
 
 
* Data are presented as the mean ± standard deviation (number of analyzed patients with adequate image 
quality). The significance of the differences between two-dimensional echocardiography (2DE), real-time three-
dimensional echocardiography (RT3DE) and cardiovascular magnetic resonance (CMR) are presented as P-
values (number of patients contributing to the paired comparisons). For all analyzed parameters and 
modalities, both papillary muscles and trabeculae were included in the left ventricular (LV) cavity. EDA, end-
diastolic area; EDD, end-diastolic diameter; EDV, end-diastolic volume; ESA, end-systolic area; ESD, end-
systolic diameter; ESV, end-systolic volume; SA, short-axis; vs, versus. Reproduced with permission of the 
publisher. 
 
Table 3 – Comparison of the LV length between 2DE, RT3DE and CMR 
 
 
 
 
 
Post-hoc analysis 
 
 
 
 
 
2DE * 
 
 
RT3DE * 
 
 
CMR * 
 
Overall 
P-value 
2DE vs 
RT3DE 
2DE vs 
CMR 
RT3DE  
vs CMR 
 
Length (mm) 
 
4CH 96 ± 10 93 ± 7 104 ± 11 < 0.0001 0.16 < 0.0001 < 0.0001 
 
 
* Data are presented as the mean ± standard deviation. The significance of the differences between two-
dimensional echocardiography (2DE), real-time three-dimensional echocardiography (RT3DE) and 
cardiovascular magnetic resonance (CMR) are presented as P-values. Both papillary muscles and trabeculae 
were included in the left ventricular (LV) cavity. 4CH, four-chamber; vs, versus 
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The 95% limits of agreement between 2DE and CMR were wide for 
the SA-EDD (MD ± SD: -1 ± 1 mm; LoA: -4 to 2 mm) and even wider 
for the 4CH-EDD (MD ± SD: -2 ± 4 mm; LoA: -10 to 5 mm). 
        Compared with CMR, 2DE underestimated the SA-EDA (Table 2) 
and 4CH-EDA (MD ± SD: -7 ± 4 cm2, p < 0.0001) significantly, but not 
the SA-ESA (Table 2). Like the linear dimensions, RT3DE 
underestimated the area to a higher degree than 2DE (Table 2). 
        2DE and RT3DE underestimated all LV volumes significantly 
compared with CMR (Table 2). Nonetheless, the degree of 
underestimation varied depending on the exclusion or inclusion of the 
trabeculae in the LV cavity (Figure 10). 
 
 
Figure 10 – Differences in the end-diastolic volume (EDV), obtained by two-
dimensional (2DE) and real-time three-dimensional echocardiography (RT3DE), 
depending on the exclusion (green dotted lines and boxes) or inclusion of the 
trabeculae in the LV cavity (red dotted lines and boxes). The significance of the 
difference in EDVs is presented as P-value. 4CH, four-chamber. Reproduced with 
permission of the publisher. 
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The degree of underestimation increased successively from diameter 
(on average by 2% for 2DE and 6% for RT3DE) to area (on average 
by 6% for 2DE and 11% for RT3DE) and finally volume (on average 
by 18% for both 2DE and RT3DE) when analyzed according to the 
same principles. 
 
4.3 Paper III 
 
Healthy volunteers without mitral regurgitation 
The comparison of the LVSV versus the AoFF (‘standard’ method,     
P < 0.0001) showed a clear tendency towards LVSV overestimation 
(Figure 11). In contrast, the comparison of the LVSV versus the RVSV 
(‘volumetric’ method, P = 0.05) and of the MiIF versus the AoFF (‘flow’ 
method, P = 0.28) displayed only small differences, as would be 
expected in healthy volunteers without MR. Nonetheless, all three 
methods had similarly wide 95% limits of agreement (Figure 11). 
 
 
Figure 11 – Bland-Altman comparison of the LVSV versus AoFF (‘standard’ method, 
red), LVSV versus RVSV (‘volumetric’ method, green) and MiIF versus AoFF (‘flow’ 
method, blue) in healthy volunteers without MR. AoFF, aortic forward flow; LoA, 95% 
limits of agreement (dashed lines); LVSV, left ventricular stroke volume; MD, mean 
difference (solid line); MiIF, mitral inflow; RVSV, right ventricular stroke volume; SD, 
standard deviation. Reproduced with permission of the publisher. 
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Patients with mitral regurgitation 
The ‘standard’ method determined clearly larger RVs and RFs, in 
contrast to the ‘volumetric’ and ‘flow’ method, which displayed similar 
MR quantification results (Table 4 and Figure 12). The 95% limits of 
agreement were narrowest when comparing the ‘standard’ versus the 
‘volumetric’ method, and broadened successively when comparing the 
‘standard’ versus the ‘flow’ method and finally the ‘volumetric’ versus 
the ‘flow’ method (Figure 12). 
 
Table 4 – Comparison of the different indirect MR quantification methods in 
patients with MR 
 
 
 
 
 
Post-hoc analysis 
 
 
 
 
 
LVSV-
AoFF 
 
 
LVSV-
RVSV 
 
 
MiIF-
AoFF 
 
 
Overall 
P-value 
 
 
LVSV-AoFF v 
LVSV-RVSV 
 
 
LVSV-AoFF v 
MiIF-AoFF 
 
 
LVSV-RVSV 
v MiIF-AoFF 
 
 
RV (ml) 
 
90 ± 31 76 ± 30 70 ± 32 < 0.0001 < 0.0001 < 0.0001 0.07 
RF (%) 
 
51 ± 11 42 ± 11 44 ± 15 < 0.0001 < 0.0001 < 0.0001 0.63 
 
 
Data are presented as the mean ± standard deviation. The significance of the differences between the different 
methods is presented as P-values. AoFF, aortic forward flow; LVSV, left ventricular stroke volume; MiIF, mitral 
inflow;  MR, mitral regurgitation; RF, regurgitant fraction; RV, regurgitant volume; RVSV, right ventricular 
stroke volume; v, versus. Reproduced with permission of the publisher. 
 
        The ‘standard’ method obtained in all operated patients with 
severe MR, as determined by 2DE, a RV above the guideline 
threshold of ≥ 60 ml. This was also the case for most of the patients 
when using the ‘volumetric’ and ‘flow’ method (86% (n=19/22) and 
83% (n=24/29) above the threshold respectively). In contrast, only the 
‘standard’ method determined for most of the patients a RF above the 
guideline threshold of ≥ 50% (76% (n=22/29)), whereas for the 
‘volumetric’ and for the ‘flow’ method, only 32% (n= 7/22) and 48% 
(n=14/29) of the patients lay above the threshold respectively. 
 35	  
 
Figure 12 – Bland-Altman comparison of the ‘standard’ (LVSV-AoFF), ‘volumetric’ 
(LVSV-RVSV) and ‘flow’ (MiIF-AoFF) method in patients with MR concerning the 
determined mitral regurgitant volume (MRV) and fraction (MRF). AoFF, aortic forward 
flow; LoA, 95% limits of agreement (dashed lines); LVSV, left ventricular stroke 
volume; MD, mean difference (solid line); MiIF, mitral inflow; RVSV, right ventricular 
stroke volume; SD, standard deviation. Reproduced with permission of the publisher. 
 
Inter- and intra-observer variability 
Inter-observer variability was lowest for the ‘flow’ method and 
increased successively via the ‘standard’ to the ‘volumetric’ method 
(Table 5). In contrast, intra-observer variability was similar for all three 
methods (Table 5). 
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Table 5 – Inter- and intra-observer variability of the RV and RF in patients with 
MR for the different indirect MR quantification methods 
 
 
 
 
 
 
Inter-observer 
variability 
 
 
Intra-observer 
variability 
 
 
 
 
 
CV 
 
 
RC 
 
 
CV 
 
 
RC 
 
 
LVSV-AoFF 
 
    RV 14 24 5 8 
    RF 7 7 2 2 
 
LVSV-RVSV 
 
    RV 18 28 7 10 
    RF 15 12 6 5 
 
MiIF-AoFF 
 
    RV 10 14 5 7 
    RF 7 6 4 4 
 
 
Data are presented as the coefficient of variation (CV) in percent and the repeatability coefficient (RC) in 
absolute values (RV in ml, RF in %). AoFF, aortic forward flow; LVSV, left ventricular stroke volume; MiIF, 
mitral inflow; MR, mitral regurgitation; RF, regurgitant fraction; RV, regurgitant volume; RVSV, right ventricular 
stroke volume. Reproduced with permission of the publisher. 
 
4.4 Paper IV 
 
Patient and CMR characteristics 
Patients with severe AR and MR had, compared with moderate 
regurgitation, significantly larger EDVs (176 ± 48 ml/m2 versus 127 ± 
20 ml/m2 (P < 0.0001) and 140 ± 20 ml/m2 versus 102 ± 15 ml/m2     
(P < 0.0001)), an increased LV mass (98 ± 31 g/m2 versus 71 ± 15 
g/m2 (P = 0.001) and 76 ± 15 g/m2 versus 57 ± 9 g/m2 (P < 0.0001)) 
and an increased LAA (MR only: 19 ± 4 cm2/m2 versus 14 ± 3 cm2/m2 
(P < 0.0001)). In contrast, no differences were observed regarding the 
EF. All operated patients with severe AR experienced a reduction in 
EDV index ≥ 15% and/or relief of symptoms. In case of severe MR, a 
reduction in the EDV index ≥ 15% was present in all but one patient, 
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who developed a reduction in the EDV index of 14% but became free 
of symptoms post-surgery.  
 
 
Figure 13 – CMR quantification of moderate (green) and severe (red) aortic 
regurgitation (AR) using a direct and an indirect method. The significance of the 
differences between moderate and severe AR as well as direct (AoFlow) and indirect 
quantification (LVSV-PuSV) is presented as P-values. Black squares represent the 
mean. AoFlow, aortic flow; LVSV, left ventricular stroke volume; PuSV, pulmonary 
stroke volume 
 
 
Figure 14 – CMR quantification of moderate (green) and severe (red) mitral 
regurgitation (MR) using two different indirect methods. The significance of the 
differences between moderate and severe MR as well as two different indirect 
quantification methods (LVSV-AoFF versus MiIF-AoFF) is presented as P-values. 
Black squares represent the mean. AoFF, aortic forward flow; LVSV, left ventricular 
stroke volume; MiIF, mitral inflow 
 38	  
        Independent of the quantification method used, AR and MR 
patients with severe regurgitation had significantly larger RV indices 
and RFs than patients with moderate regurgitation (Figure 13 and 14). 
In both moderate and severe AR, the indirect quantification method 
(LVSV-PuSV) determined larger RV indices and RFs than the direct 
quantification method (Figure 13). Furthermore, in both moderate and 
severe MR, the indirect quantification method using a combination of 
PC imaging and slice summation technique (LVSV-AoFF) obtained 
larger RV indices and RFs than the indirect method using solely PC 
imaging (MiIF-AoFF; Figure 14). 
 
Identification of hemodynamically significant regurgitation 
benefiting from surgery 
In operated patients with severe AR or MR, as determined by 2DE, 
the application of current guideline RF thresholds led frequently to 
discordant grading by CMR and was, furthermore, dependant on the 
CMR quantification method used (Figure 15). 
        CMR specific thresholds for the EDV index, myocardial mass 
index (AR only), LAA index (MR only), RV index and RF (for each 
quantification method) indicating hemodynamically significant AR or 
MR benefiting from surgery were determined using ROC analyses 
(Table 6 and 7). The diagnostic accuracy, indicated by the area under 
the curve, was good in AR and good to excellent in MR. 
        In AR, the discriminatory ability was strong for the EDV index, the 
RV index using both methods and the RF using the indirect method 
with a low NLR (< 0.2). Solely the RV index using the indirect method 
had also a PLR with a strong discriminatory ability (> 5). The weakest 
discriminatory power was observed for the myocardial mass index 
(Table 6). 
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Figure 15 – Discordance between two-dimensional echocardiography (2DE) and 
cardiovascular magnetic resonance (CMR) in the grading of chronic aortic (AR) and 
mitral regurgitation (MR). In operated patients with severe AR or MR, as determined 
by 2DE, the application of current guideline regurgitant fraction thresholds led 
frequently to discordant grading by CMR in a method-dependant manner.  
 
        In MR, the discriminatory power was in general stronger than in 
AR. The discriminatory ability was very strong for the EDV index, RV 
index and RF using both methods with a low NLR (< 0.1). Both the 
EDV index and RF (MiIF-AoFF) showed PLRs with very strong 
discriminatory abilities (> 10). The strongest discriminatory power was 
observed for the RV index (MiIF-AoFF) and the weakest for the LAA 
index (Table 7).         
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Table 6 – Diagnostic performance of thresholds indicating hemodynamically 
significant chronic aortic regurgitation benefiting from surgery 
 
 
 
 
 
 
AUC 
(95% CI) 
 
 
Threshold 
 
 
Sensitivity 
(95% CI) 
 
 
Specificity 
(95% CI) 
 
 
PLR 
(95% CI) 
 
 
NLR 
(95% CI) 
 
 
EDV index 
(ml/m2) 
 
0.85  
(0.72 – 0.98) 
> 135 87 
(68 – 96) 
73 
(48 – 89) 
3.3 
(1.4 – 7.7) 
0.18 
(0.06 – 0.53) 
Mass index 
(g/m2) 
 
0.82 
(0.68 – 0.96) 
> 79 78 
(58 – 90) 
80 
(55 – 93) 
3.9 
(1.4 – 11.0) 
0.27 
(0.12 – 0.61) 
    AoFlow 
    RV index    
    (ml/m2) 
 
0.89 
(0.79 – 0.99) 
> 20 87 
(68 – 96) 
73 
(48 – 89) 
3.3 
(1.4 – 7.7) 
0.18 
(0.06 – 0.53) 
    RF (%) 
 
 
0.89 
(0.79 – 0.99) 
> 30 87 
(68 – 96) 
67 
(42 – 85) 
2.6 
(1.3 – 5.4) 
0.20 
(0.06 – 0.60) 
    LVSV-PuSV 
    RV index  
    (ml/m2) 
 
0.90 
(0.80 – 1.0) 
> 31 87 
(68 – 96) 
87 
(62 – 96) 
6.5 
(1.8 – 23.9) 
0.15 
(0.05 – 0.44) 
    RF (%) 
 
 
0.92 
(0.82 – 1.0) 
> 36 91 
(73 – 98) 
80 
(55 – 93) 
4.6 
(1.7 – 12.7) 
0.11 
(0.03 – 0.42) 
 
 
AoFlow, aortic flow; AUC, area under the curve; CI, confidence interval; EDV, end-diastolic volume; LVSV, left 
ventricular stroke volume; NLR, negative likelihood ratio; PLR, positive likelihood ratio; PuSV, pulmonary 
stroke volume; RF, regurgitant fraction; RV, regurgitant volume 
 
Table 7 – Diagnostic performance of thresholds indicating hemodynamically 
significant chronic mitral regurgitation benefiting from surgery 
 
 
 
 
 
 
AUC 
(95% CI) 
 
 
Threshold 
 
 
Sensitivity 
(95% CI) 
 
 
Specificity 
(95% CI) 
 
 
PLR 
(95% CI) 
 
 
NLR 
(95% CI) 
 
 
EDV index 
(ml/m2) 
0.96 
(0.91 – 1.0) 
 
> 120 92 
(75 – 98) 
93 
(70 – 99) 
13.8 
(2.1 – 92.0) 
0.09 
(0.02 – 0.33) 
LAA index 
(cm2/m2) 
0.88 
(0.78 – 0.98) 
 
> 15 84 
(65 – 94) 
73 
(48 – 89) 
3.2 
(1.3 – 7.4) 
0.22 
(0.08 – 0.56) 
    LVSV-AoFF 
    RV index   
    (ml/m2) 
0.98 
(0.96 – 1.0) 
 
> 32 96 
(81 – 99) 
80 
(55 – 93) 
4.8 
(1.7 – 13.3) 
0.05 
(0.01 – 0.35) 
    RF (%) 0.92 
(0.82 – 1.0) 
 
> 41 96 
(81 – 99) 
80 
(55 – 93) 
4.8 
(1.7 – 13.3) 
0.05 
(0.01 – 0.35) 
    MiIF-AoFF 
    RV index  
    (ml/m2) 
1.0 
(1.0 – 1.0) 
 
> 20 100 
(87 – 100) 
100 
(80 – 100) 
- - 
    RF (%) 0.99 
(0.97 – 1.0) 
 
> 30 96 
(81 – 99) 
93 
(70 – 99) 
14.4 
(2.2 – 95.8) 
0.04 
(0.01 – 0.29) 
 
 
AoFF, aortic forward flow; AUC, area under the curve; CI, confidence interval; EDV, end-diastolic volume; 
LAA, left atrial area; LVSV, left ventricular stroke volume; MiIF, mitral inflow; NLR, negative likelihood ratio; 
PLR, positive likelihood ratio; RF, regurgitant fraction; RV, regurgitant volume 
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5 DISCUSSION 
 
5.1 Echocardiographic LV volumes can support the 
diagnosis of severe chronic AR or MR (Paper I) 
In paper I, our findings indicate that both 2DE and RT3DE LV 
volumetric dimensions can support the diagnosis of severe chronic AR 
and MR, in contrast to the LV linear dimensions. Our proposed 
threshold values are based on a novel study design, which used CMR 
as reference to determine the true degree of LV dilatation in patients 
with hemodynamically significant regurgitation and proven surgical 
benefit. 
        As previously mentioned, the quantification of LV size and 
function is an essential part of the evaluation and management of 
patients with VHD (5,6,54-56). Current guidelines define the upper 
normal limits for LV linear and volumetric dimensions obtained by 2DE 
as well as RT3DE, and these thresholds are useful to support the 
presence of a mild regurgitation, but cannot be used to distinguish 
between moderate and severe regurgitation (54-56,85,86). 
Furthermore, current guidelines refer to LV linear dimensions 
indicating severe LV dilation with poor prognosis (5,6), but contain 
otherwise no reference values concerning LV dimensions that can 
further aid in the diagnosis of severe AR or MR. Our results 
demonstrate that echocardiographic LV linear dimensions are only 
moderately related to LV volumes obtained by CMR. This is in 
accordance with previous findings looking at the agreement between 
LV linear and volumetric dimensions both obtained by CMR (104). 
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This implies that the sole assessment of the one-dimensional LV 
linear dimensions as a marker of LV enlargement, which is a three-
dimensional process, can lead to underestimation of the true 
regurgitation severity, as the true extent of LV dilatation is not 
captured. Therefore, LV volumetric dimensions are preferable to linear 
dimensions, as our results indicate. Currently, echocardiographic 
grading of regurgitation severity is based on an “integrative approach” 
combining results from several qualitative, semi-quantitative and 
quantitative parameters (54-56). Eccentric jets are a frequent finding 
in patients undergoing both aortic and mitral valve surgery due to a 
bicuspid valve (AR) or degenerative valve disease (MR), which 
implies problems for the standard echocardiographic parameters used 
for the grading of regurgitation severity. In these cases, the 
echocardiographic diagnosis is challenging due to fewer diagnostically 
reliable parameters, as the vena contracta is difficult to measure, the 
flow convergence zone is not hemispheric and the continuous Doppler 
signal is suboptimal due to incorrect alignment between the flow and 
ultrasound beam direction. Consequently, grading of regurgitation 
severity is often inconclusive or incongruent. In this context, the 
assessment of LV dilatation, as an additional marker, becomes even 
more important and might aid in the clinical decision-making, 
especially in cases of uncertainty. Severe chronic AR and MR cause 
marked LV dilatation and this finding strongly supports the diagnosis 
of severe regurgitation, as our data illustrates. Importantly, other 
causes of LV enlargement have to be considered especially in 
patients with reduced systolic function. Consequently, LV volumes as 
a supportive sign in the grading of regurgitation severity should be 
interpreted with caution if other relevant causes contributing to LV 
dilatation and/or reduced systolic function (LVEF < 50%) are present, 
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for instance ischemic heart disease. Since chronic AR is characterized 
by a combined volume and pressure overload, in contrast to pure 
volume overload in chronic MR, we observed also a difference in the 
LV remodeling process, with significantly larger EDVs in patients with 
AR. This was also the reason why we determined separate thresholds 
for both AR and MR. 
        The assessment of LVEF is important in patients with severe 
chronic regurgitation, especially among those who are asymptomatic. 
Our results show that only the LVEF from 2DE data showed a 
moderate agreement with CMR. In contrast, the LVEF based on either 
LV linear dimensions or RT3DE data significantly underestimated the 
LVEF in comparison with CMR and the agreement was poor. This 
suggests that the threshold to perform CMR should be low in 
asymptomatic patients to facilitate correct clinical decision-making and 
timing of surgery. Although serial assessment of LV dimensions and 
LVEF is best performed using CMR, the differences in reproducibility 
between 2DE, RT3DE and CMR are not large (data only shown in the 
manuscript). Thus, we suggest that in clinical practice the serial 
evaluation using 2DE or RT3DE should be sufficient in most cases 
and that the role of CMR for serial evaluation can be limited to 
patients with suboptimal echocardiographic image quality. 
 
Study limitations 
CMR provides currently the most exact assessment of LV volumes. 
Nonetheless, the method has several limitations, discussed in detail in 
the following sections 5.2 and 5.3, which might explaining some of the 
observed differences between the modalities. 
        The recent 2015 guidelines on “Cardiac Chamber Quantification” 
recommend for the assessment of LV volumes by both 2DE and 
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RT3DE, to delineate the endocardial border between the trabeculae 
and the compact myocardium (105). This will, as we have shown in 
paper II (106), reduce the differences between 2DE and RT3DE LV 
volumes, but we were hesitant to do so in this study as this border is 
difficult to identify and the method is still poorly described in the 
literature as well as in the current guidelines. Therefore, in order to 
maintain high reproducibility, we used the old 2DE definition of the 
endocardial border, where the trabeculae are excluded from the LV 
cavity (85). Furthermore, it should be kept in mind that so far no 
reference values exits for the new delineation method of the 
endocardial border for LV dimensions obtained by 2DE. 
 
5.2 The main cause of echocardiographic under-
estimation of LV dimensions (Paper II) 
In the second paper, we systematically analyzed the ability of 2DE, 
RT3DE and CMR to delineate dimensions with increasing complexity 
(diameter – area – volume) in a multimodality phantom model, as well 
as in vivo. Using this study design, we hoped to gain a clearer picture 
of the main cause of echocardiographic underestimation by assuming 
that the simplest one-dimensional parameters, like diameter, are 
influenced to a lesser degree by interfering factors than the more 
complex two- and three-dimensional parameters, like area and 
volume. 
        Our in vivo results show that the smallest degree of 
underestimation between 2DE and CMR existed for the LV end-
diastolic linear dimensions in the SA projection due to a good detail in 
the echocardiographic image that enabled a sufficient differentiation 
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between trabeculated and compact myocardium. An even clearer 
differentiation was possible in end-systole, leading to an only small 
and non-significant difference between the modalities. We found 
similar results for the areal dimensions in SA, although the degree of 
underestimation increased for the end-diastolic dimensions. 
Interestingly, the degree of underestimation by RT3DE, when 
analyzing the linear and areal LV dimensions in SA, was significantly 
larger than for 2DE. The most likely explanation for this is that RT3DE 
SA projections were reconstructed by post-processing a data set 
acquired from the apical window. In general, projections that were 
acquired from the apical window had often a lower image detail in 
certain areas of the heart (especially the lateral wall in the 4CH and 
the anterior wall in the two-chamber view) than images obtained from 
the parasternal window. This resulted in an inferior ability to 
differentiate between trabeculated and compact myocardium, and 
consequently in a higher degree of underestimation. This is clearly 
illustrated by the 95% limits of agreement that were narrow for the SA-
EDD and wide for the 4CH-EDD. As initially postulated, increased the 
degree of underestimation successively from linear to areal, and 
finally volumetric LV dimensions. When analyzed according to the 
same principles, 2DE and RT3DE determined similar LV volumes. 
This stands in clear contrast to previous studies, which showed 
significantly larger volumes for RT3DE than for 2DE (61,63). The main 
reason for this discrepancy is most likely due to differences in the 
endocardial border definition. According to guidelines, only the 
papillary muscles are included in the LV cavity for 2DE (85), whereas, 
in RT3DE, as in CMR, both the trabeculae and the papillary muscles 
are included in the LV cavity (86). When applying these guideline 
recommendations, our results were once again in agreement with 
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previous studies and the results from paper I. Furthermore, the close 
agreement between the 2DE and RT3DE results enable us to 
conclude that the presumed limitation of 2DE, using geometrical 
assumptions to calculate LV volumes according to the biplane method 
of disks, did not play an essential role in our study population as most 
of the hearts retained their symmetry. However, in the presence of 
irregular LV shapes and/or regional wall motion abnormalities 
geometrical assumptions can contribute to the differences between 
2DE and RT3DE (70). Altogether, our findings clearly indicate that the 
underestimation of LV dimensions by 2DE and RT3DE in comparison 
with CMR is mainly due to inherent technical differences in the ability 
to differentiate trabeculated from compact myocardium. Using a 
different approach, Mor-Avi et al. (72) came to a similar conclusion, 
which was based on the observation that the exclusion of trabeculae 
from the LV cavity during volumetric analysis of interpolated 3D CMR 
data sets improved the agreement between RT3DE and CMR in a 
small number of patients. Taken together, these findings clearly 
indicate that heterogeneous criteria for endocardial border definition 
are an additional contributor to the differences between the modalities. 
Consequently, a uniform endocardial border definition is desirable and 
a prerequisite for comparisons across modalities. Therefore, to 
minimize the inter-modality discrepancies and to improve the accuracy 
of the most widely used imaging method for LV assessment, namely 
echocardiography, we advocate that both the papillary muscles and 
trabeculae should be included in the LV cavity for the assessment of 
all LV dimensions for all modalities. 
        Interestingly, the latest version of the echocardiographic 
guidelines on “Cardiac Chamber Quantification”, which have been 
published after this paper was initially submitted for publication, state 
 47	  
that for both 2DE and RT3DE the “volumetric measurements are 
usually based on tracings of the interface between the compacted 
myocardium and the LV cavity” (105). Concerning LV linear 
dimensions, the guidelines state that they should be delineated “on 
the interface between the myocardial wall and cavity” (105). These 
statements are still quite vague and a clear definition of how to identify 
the endocardial border on echocardiographic images is once again 
missing, most likely due to the lack of sufficient studies in this area. 
Therefore, further studies are needed to clearly define the endocardial 
border in a sufficient and reproducible way. 
        Using the current phantom study, it was possible to rule out 
calibration errors by the imaging and analysis systems as a reason for 
echocardiographic underestimation, and previous results were thereby 
supported (72). Nonetheless, additional factors, apart from those 
previously discussed, could have contributed to the discrepancy 
between the modalities. Much attention was paid to assure high image 
quality, equivalent measurement positions and to avoid LV 
foreshortening as well as off-axis views, factors we sought to minimize 
by using experienced examiners. One known problem when it comes 
to CMR is the tendency towards LV volume overestimation due to 
insufficient compensation for basal through-plane motion, an error we 
tried to minimize using a method previously described by Alfakih et al. 
(97). Furthermore, small differences in the endocardial border position 
can have significant effects on the determined dimensions (72), a 
factor we sought to minimize by using experienced examiners and 
clear criteria for the delineation of the endocardial border. 
 
Underlying physical principles 
In the following section, we will take a closer look at the underlying 
abcdefghijklmnopqrstuvwxyzabcdefghijklmnopqrst 
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physical principles, which determine the detail in an image, and will 
speculate on how they might further explain our findings:  
 
The detail in an image, which enables a clear differentiation between 
trabeculated and compact myocardium, is determined by the spatial 
resolution, contrast and noise of the respective imaging modality. 
        Spatial resolution in echocardiography is determined by 
components in three directions: axial, lateral and elevational resolution 
(107-109). In CMR, on the other hand, spatial resolution is determined 
by the slice thickness and image matrix that in turn is dependant on 
the number of frequency-encoded and phase-encoded projections for 
a given field of view (110-113). It is known that echocardiography, in 
comparison with CMR, has a better or similar in-plane spatial 
resolution in the axial and at the focus position of the lateral direction. 
Nonetheless, the depth-dependant lateral resolution, which is overall 
inferior to the axial resolution, might lead to fusion of trabeculae with 
compact myocardium, as they can no longer be sufficiently separated 
as individual structures, especially in certain regions of the near and 
far field of the ultrasound beam. Interestingly, despite a superior axial 
resolution, our 2DE and RT3DE results depicted the LV as 
significantly shorter in comparison with CMR (data not included in the 
published article). This is in accordance with previous findings by 
Jenkins et al. (114). The simplest explanation would be LV 
foreshortening due to improper image alignment by 2DE and RT3DE, 
although much care was taken to avoid this. A further more likely 
cause for this discrepancy is the occurrence of apical trabeculations, 
which cannot be delineated sufficiently as separate structures. Even 
the fact that lateral resolution is poorer in the near field close to the 
transducer surface and that the usage of tissue harmonic imaging 
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improves lateral resolution but reduces axial resolution has to be 
taken into account as possible contributing causes (115). An 
additional factor that can impair the lateral resolution in 
echocardiography is a reduced scan line density, for instance due to a 
large scan volume in RT3DE, as in patients with valvular heart 
disease (116). 
        Contrast in echocardiography depends on the difference in 
acoustic impedance and attenuation of adjacent tissues/materials as 
well as spatial resolution (107-109). In CMR, on the other hand, 
contrast is determined by the type of pulse sequence, difference in T1 
and T2 relaxation times and proton density of adjacent tissues (110-
113). The currently most widely used balanced steady-state free 
precession sequences for LV assessment depend for their signal on 
the square root of the T2/T1 ratio and the proton density, thus 
providing a good contrast between blood and adjacent myocardium 
(117). In contrast, older spoiled gradient-echo sequences with their 
poorer contrast and thereby poorer visualization of the endocardial 
border lead to significantly smaller LV volumes (118). Under optimal 
conditions, as illustrated by our phantom results, echocardiography 
can in the presence of sufficient contrast delineate dimensions with 
similar precision as CMR apart from the effect of a depth-dependant 
lateral resolution. During the echocardiographic exam of the phantom 
model good contrast was provided due to a high difference in acoustic 
impedance and attenuation between water with added potato flower 
(~1.48 x 106 kg/(m2s) and ~0.0002 (dB/cm)/MHz respectively) and 
polycarbonate (~2.69 x 106 kg/(m2s) and ~4.98 (dB/cm)/MHz 
respectively) as well as a specular reflector in form of a smooth 
surface providing a good signal-to-noise ratio and thereby a good 
contrast-to-noise ratio. In contrast, in vivo the difference in acoustic 
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impedance and attenuation between blood (~1.65 x 106 kg/(m2s) and 
~0.18 (dB/cm)/MHz respectively) and myocardium (~1.71 x 106 
kg/(m2s) and ~0.5 (dB/cm)/MHz respectively) is much smaller and the 
trabeculations with their irregular surface provide a non-specular 
reflector, which in turn results in more attenuation due to scattering 
and thereby to a poorer signal-to-noise ratio and contrast-to-noise 
ratio. Another factor contributing to a poorer signal-to-noise ratio and 
contrast-to-noise ratio is the non-perpendicular incidence of 
ultrasound waves with tissue boundaries in certain areas of the heart, 
especially when using images obtained from the apical window. It is 
known that CMR has a superior image contrast compared with 
echocardiography even when adding ultrasound contrast. 
Nonetheless, the application of ultrasound contrast can lead to an 
improvement in the endocardial border definition and is a potential 
solution to improve the echocardiographic contrast (114,119). 
        Further studies are needed to clarify the exact effect of the 
differences in spatial resolution, contrast and noise, as well as their 
determinants, as the possible underlying main cause of the 
underestimation of LV dimensions by 2DE and RT3DE in comparison 
with CMR. 
 
Study limitations 
Importantly, the study has to cope with a sampling bias as patients 
with a severely dilated LV had more frequently a 2DE and RT3DE 
data set that did not fulfill our strict analysis criteria. Since the extent 
of underestimation increases with the severity of LV dilatation (120), it 
is most likely that in reality the degree of echocardiographic 
underestimation is larger than reported in paper II. 
 
 51	  
5.3 The choice of CMR quantification method can 
affect the grading of MR severity (Paper III) 
In paper III, we systematically compared three different CMR methods 
for indirect MR quantification. In healthy volunteers without MR, our 
results showed a clear tendency of the ‘standard’ method towards 
LVSV overestimation resulting, accordingly, in larger RVs and RFs in 
patients with MR, in contrast to the ‘volumetric’ and ‘flow’ method, 
which determined similar results. Consequently, the choice of method 
can affect the grading of MR severity. Inter-observer variability was 
lowest for the ‘flow’ and highest for the ‘volumetric’ method, while 
intra-observer variability was similar for all three methods. 
        Each indirect method uses either the slice summation technique 
and/or PC imaging, solely or in combination, for MR quantification. 
The slice summation technique provides currently the most exact 
ventricular volumes, nonetheless, has the technique certain 
limitations. The inclusion or exclusion of the papillary muscles and 
trabeculae in the ventricular cavity affect the determined ventricular 
volumes significantly (121). In the current study, we included both the 
papillary muscles and trabeculae in the ventricular cavity, a technique 
often used in clinical practice due to its good reproducibility, which 
leads, nonetheless, to larger EDVs, ESVs and SVs (122). 
Furthermore, inconsistent inclusion in end-diastole and unintentional 
exclusion of trabeculae in end-systole, as the differentiation between 
compact and trabeculated myocardium becomes more difficult, can 
lead to overestimation of the determined SV. Another factor 
influencing the determined ESV and SV is the phenomenon of 
through-plane motion of the basal slice (73), an error we aimed to 
minimize using a method previously described by Alfakih et al (97). 
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This method, although easy to apply and widely used, is not entirely 
correct since it does not take the left ventricular outflow tract and the 
shape of the mitral valve into account. Furthermore, accurate 
differentiation between the left ventricle and left atrium is difficult due 
to a partial volume effect. Altogether, these factors are most likely the 
explanation for the in the study observed tendency of the ‘standard’ 
method towards LVSV overestimation resulting, consequently, in 
larger RVs and RFs in patients with MR. PC imaging, on the other 
hand, allows accurate quantification of cardiac blood flow (90,123), 
and has been shown to correspond well to Doppler echocardiography 
as well as fair to invasive techniques (123,124). Nonetheless, PC 
imaging has in general to cope with certain pitfalls and limitations as 
caused by mismatch of the encoding velocity, misalignment of the 
image plane, inadequate temporal resolution, inadequate spatial 
resolution/partial volume effects, accelerated flow, spatial 
misregistrations, signal loss and/or BPEs (90,98,125). We aimed, as 
previously described in the methods section, to minimize these pitfalls 
and limitations among others through accurate alignment and 
positioning of the imaging slice, setting of an adjusted VENC and 
correction for BPEs (90). Furthermore, it has previously been shown 
that the position of the imaging slice in the aortic as well as the mitral 
position is important for flow quantification by CMR (79,90,126). In 
accordance with previous recommendations, the AoFF was 
determined at the level of the sinutubular junction (90). To quantify the 
MiIF, we chose an imaging slice position approximately 1 cm below 
the mitral annulus (ventricular side), which can, according to previous 
results, lead to a significantly smaller MiIF in comparison to the mitral 
annulus position (79). This might have contributed to a slight 
underestimation of the MiIF and thereby MRVs, but according to our 
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own experience, the chosen method provided more reproducible 
measurements (results not shown). The motion of the aortic and mitral 
valve is a further complicating factor of PC imaging since it interferes 
with the appropriate positioning of the imaging slice. Moving slice PC 
imaging has been developed to overcome this problem, a method that 
determined considerably larger MRFs than without correction (127). 
This is a highly complex technique with limited availability. 
Nonetheless, we have tested this technique at our institution but were 
not convinced of its applicability. 
        Previous studies reported smaller differences when comparing 
the ‘standard’ versus the ‘volumetric’ method (80,81). Nonetheless, a 
direct comparison with our results is difficult as both studies used 
either gradient echo sequences to obtain ventricular volumes, 
resulting in smaller volumes, or different analysis tools, which exclude 
the papillary muscles from the ventricular cavity and use a different 
approach for basal through-plane motion compensation. PC imaging 
has, as shown by our results and in accordance with previous 
findings, a lower inter- and intra-observer variability than the slice 
summation technique as well as a low variability for repeated 
measurements (97,123). As a consequence, we observed, in 
accordance with previous studies, the lowest variability for the ‘flow’ 
and the highest variability for the ‘volumetric’ method as it uses the 
slice summation technique twice (79,81). A major limitation of the 
‘volumetric’ method is concomitant tricuspid regurgitation, a common 
finding in MR patients, as the method can only be applied in the 
absence of multivalvular disease and intra-cardiac shunt. This makes 
the ‘volumetric’ method, together with its high variability, to the least 
favorable of the three methods. 
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        In a subgroup of operated patients with severe MR, we were able 
to show that the choice of method can affect the grading of MR 
severity and thereby eventually the clinical decision-making and timing 
of surgery. Furthermore, the RVs were, irrespective of the chosen 
method, in most cases above the guideline threshold of ≥ 60 ml, while 
the RFs were more frequently below the threshold of ≥ 50% (5). 
Consequently, diagnostic incongruence between the calculated RV 
and RF was a frequent finding in this study. Hereby should be kept in 
mind that a certain degree of diagnostic incongruence will merely 
occur due to patients that lie just above or below the respective 
threshold. These findings clearly indicate, in accordance with previous 
studies (83,84), that CMR-specific thresholds for severe regurgitation 
might differ from recognized guideline cut-off values. This was further 
investigated in the fourth paper of this thesis.  
 
Study limitations 
A limiting factor, as for all other studies investigating the diagnostic 
accuracy for MR quantification, is the lack of a true “gold standard”. 
Therefore, it is difficult to say, which method is the most accurate and 
reliable. Nonetheless, healthy volunteers without MR were included in 
the study design as a control group and uncovered a clear tendency 
of the ‘standard’ method towards LVSV overestimation. 
 
5.4 CMR grading thresholds indicating hemo-
dynamically significant AR or MR (Paper IV)   
In the fourth paper, the application of current guideline RF thresholds 
led to frequently discordant grading between 2DE and CMR. 
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Furthermore, we were able to determine quantification method-
specific thresholds for CMR RV indices and RFs indicating 
hemodynamically significant chronic AR or MR benefiting from 
surgery, which are lower than the recognized guideline criteria. 
Furthermore, we provide thresholds for EDV indices supporting the 
diagnosis of hemodynamically significant chronic regurgitation. 
        As previously mentioned, accurate grading of regurgitation 
severity is of utmost clinical importance, but one of the most difficult 
problems in valvular heart disease. Currently, CMR grading of AR and 
MR severity is usually based on the same thresholds as 
echocardiography, which were originally defined through the 
calibration of quantitative Doppler echocardiography against 
angiographic grading of regurgitation severity (54,68). However, 
angiographic grading itself has several limitations and is, nowadays, 
considered inferior to echocardiography. Furthermore, the relation 
between quantitative Doppler echocardiography and CMR has only 
been studied in a small number of patients, of which even fewer 
patients fulfilled the criteria for severe regurgitation (78,128). 
Consequently, the approach to identify CMR-specific thresholds by 
using another modality as reference is difficult, since each reference 
method has its own limitations. To avoid this drawback, we used 
patients with proven hemodynamically significant regurgitation and 
surgical benefit as reference, defined by a post-surgical reduction in 
EDV index of ≥ 15% and/or relief of symptoms. Clearly, the hypothesis 
that post-surgical reverse remodeling and/or relief of symptoms are 
solely related to the surgical correction of valvular regurgitation is an 
oversimplification, but in the context of previous studies a reasonable 
approximation (24,129). Nonetheless, several other factors could have 
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contributed as well, as changes in medication or physical activity or 
cardiac rhythm. 
        Our determined quantification method-specific CMR RF 
thresholds indicating hemodynamically significant chronic AR or MR 
benefiting from surgery were lower than the recognized guideline 
thresholds for severe regurgitation (5). No comparison was possible 
concerning RV indices, as no reference values are reported in current 
guidelines. Our identified CMR-specific thresholds are in keeping with 
two previous studies on chronic AR, which used two completely 
different study designs. The first study by Myerson et al. (84), looking 
for the link between clinical outcome and CMR grading of regurgitation 
severity, identified several quantitative parameters, which were 
associated with the development of symptoms and/or progression to 
surgery, including a RV index > 23 ml/m2 and RF > 33% using the 
direct quantification method. The second study by Gabriel et al. (83), 
looking for the best concordance between echocardiographic and 
CMR grading of regurgitation severity, identified a RF > 30% as 
threshold for severe regurgitation when using the direct quantification 
method. In contrast to our and previous findings, stands a third study 
on AR and MR by Gelfand et al. (82), which looked once again for the 
best concordance between echocardiographic and CMR grading of 
regurgitation severity. This study identified a RF > 48% as threshold 
for both severe AR and MR, using direct quantification for AR and 
indirect quantification (LVSV-AoFF) for MR respectively. 
        The clear quantification method-dependence of both AR and MR 
grading is in accordance with our previous findings in MR patients 
(Paper III) (130). In general, methods using a combination of PC 
imaging and the slice summation technique determined in both AR 
and MR larger RV indices and RFs than methods using solely PC 
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imaging. Possible explanations for these observed differences are the 
tendency of the slice summation technique towards LVSV 
overestimation, the potential for underestimation of AoFF and PuSV 
using PC imaging or both (discussed in detail in the previous section 
5.3). Interestingly, the obtained thresholds indicating severe AR and 
MR were identical for quantification methods using solely PC imaging 
and similar for quantification methods using a combination of PC 
imaging and slice summation technique. This finding is in accordance 
with current guidelines and the previously mentioned study by Gelfand 
et al. (82). 
        Furthermore, our findings indicate that the application of current 
guideline RF thresholds leads in operated patients with severe AR or 
MR, as determined by 2DE, to frequently discordant grading as 
moderate or even mild regurgitation by CMR. A finding, which is in 
agreement with recent results in patients with MR by Uretsky et al. 
(129). Since CMR is often used as a second line diagnostic tool in 
cases of echocardiographic uncertainty, this downgrading by CMR 
can potentially delay surgery in patients that otherwise would benefit 
from intervention. 
        Our results show that the EDV index, as indicator of the degree 
of LV remodeling, can be of additive value supporting the diagnosis of 
hemodynamically significant regurgitation. This expands the current 
diagnostic arsenal and may especially be useful in cases of diagnostic 
uncertainty. Importantly, other causes of LV dilation have to be 
excluded prior to the application of this parameter, especially in 
patients with LV systolic dysfunction. This is in accordance with our 
findings in paper I and a previous CMR study, which identified in 
patients with AR an EDV index > 129 ml/m2 as threshold associated 
with poorer prognosis (84). 
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Study limitations 
The relatively small number of highly selected patients limits the 
strength of our conclusions as well as the general applicability of the 
obtained thresholds. This is of special importance in the group of 
patients with severe MR, which had in relation to patients with 
moderate regurgitation, clearly larger RV indices and RFs. Although 
both groups had degenerative disease with prolapse (apart from one 
patient), it is conceivable that an additional chordae rupture will 
worsen the degree of regurgitation significantly, resulting in a clear 
distinction between moderate and severe MR. Consequently, our MR 
thresholds should be interpreted with caution and not extrapolated to 
patients with functional MR. However, our findings are of clinical 
relevance as the majority of MR patients undergoing surgery have, 
nowadays, degenerative disease with prolapse. In the present study, 
special care was taken to assure high accuracy of PC imaging. 
Nonetheless, several factors could have contributed to eventual 
underestimation of the quantified flow: valvular motion, choice of slice 
positioning and altered flow patterns due to a bicuspid aortic valve or 
dilated ascending aorta (90,126,131-134). Consequently, the highest 
risk for underestimation exists for the direct AR quantification method. 
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6 CONCLUSIONS 
 
• We propose 2DE and RT3DE thresholds for LV volumes 
indicating severe chronic AR or MR, which can support the 
diagnosis of severe chronic regurgitation. Importantly, prior to 
the application of these thresholds, other causes for LV 
enlargement have to be considered, especially in patients with 
reduced LVEF. Furthermore, LV volumetric dimensions are 
superior to linear dimensions in the assessment of LV 
dilatation, and 2DE is still more feasible and superior to 
RT3DE in the assessment of LV volumes and systolic function 
in this patient group. 
 
• Underestimation of LV dimensions by 2DE and RT3DE 
compared with CMR is mainly due to inherent technical 
differences in the ability to differentiate trabeculated from 
compact myocardium. Identical endocardial border definition 
criteria are needed to minimize differences between the 
modalities and to ensure better comparability in clinical 
practice. 
 
• In healthy volunteers without MR, the ‘standard’ method shows 
a clear tendency towards LVSV overestimation resulting, 
accordingly, in larger RVs and RFs in patients with MR, in 
contrast to the ‘volumetric’ and ‘flow’ method, which determine 
similar MR quantification results. Consequently, the choice of 
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method can affect the grading of MR severity and thereby 
eventually the clinical decision-making and timing of surgery. 
 
• CMR grading of chronic AR and MR severity based on current 
guideline criteria leads to frequent downgrading compared with 
2DE. Furthermore, our findings indicate that CMR grading of 
chronic AR and MR should be based on modality- and 
quantification method-specific thresholds, as they differ from 
recognized guideline criteria and are dependant on the 
quantification method used, to assure appropriate clinical 
decision-making and timing of surgery. Finally, we propose 
CMR- and quantification method-specific thresholds indicating 
hemodynamically significant AR or MR benefiting from 
surgery. 
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FUTURE PERSPECTIVES 
 
Much remains to be done in the field of VHD, both from a clinical as 
well as diagnostic perspective. Focusing on the diagnosis using non-
invasive imaging techniques, the spectrum of remaining problems is 
rather broad, as highlighted by our research, ranging from basic 
methodological problems to more complex multi-parametric analysis 
approaches. To improve the most important diagnostic challenge, 
namely the grading of regurgitation severity, we need a better 
understanding of the natural history of VHD and continue our search 
for new diagnostic parameters as well as techniques. Hereby, we 
should not only focus on the diseased valve itself, but also on the 
resulting altered flow patterns, remodeling processes and systemic 
effects. A multi-parametric grading approach, looking at different 
aspects of the disease, will most likely hold the key to success. To 
achieve this, further studies are needed to find the right combination 
of already existing as well as new diagnostic parameters that take not 
only different imaging parameters into account but also biochemical 
and molecular markers. 
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